相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Vitamin D, PTH, and calcium and the risk of prostate cancer: a prospective nested case-control study
Johan Brandstedt et al.
CANCER CAUSES & CONTROL (2012)
Cancer risk after hospitalization for osteoporosis in Sweden
Jianguang Ji et al.
EUROPEAN JOURNAL OF CANCER PREVENTION (2012)
Safety of Osteoanabolic Therapy: A Decade of Experience
Cristiana Capriani et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2012)
The US Postmarketing Surveillance Study of Adult Osteosarcoma and Teriparatide: Study Design and Findings From the First 7 Years
Elizabeth B. Andrews et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2012)
Low bone mineral density is associated with increased risk for myocardial infarction in men and women
P. Wiklund et al.
OSTEOPOROSIS INTERNATIONAL (2012)
Mechanisms for the bone anabolic effect of parathyroid hormone treatment in humans
Derya Aslan et al.
SCANDINAVIAN JOURNAL OF CLINICAL & LABORATORY INVESTIGATION (2012)
Prediagnostic Circulating Parathyroid Hormone Concentration and Colorectal Cancer in the European Prospective Investigation into Cancer and Nutrition Cohort
Veronika Fedirko et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2011)
The Danish National Prescription Registry
Helle Wallach Kildemoes et al.
SCANDINAVIAN JOURNAL OF PUBLIC HEALTH (2011)
The Danish National Patient Register
Elsebeth Lynge et al.
SCANDINAVIAN JOURNAL OF PUBLIC HEALTH (2011)
Serum levels of vitamin D, PTH and calcium and breast cancer risk-a prospective nested case-control study
Martin Almquist et al.
INTERNATIONAL JOURNAL OF CANCER (2010)
Of mice and men: divergent risks of teriparatide-induced osteosarcoma
V. Subbiah et al.
OSTEOPOROSIS INTERNATIONAL (2010)
Mortality following the diagnosis of a vertebral compression fracture in the Medicare population
Edmund Lau et al.
JOURNAL OF BONE AND JOINT SURGERY-AMERICAN VOLUME (2008)
Sarcoma epidemiology and etiology: Potential environmental and genetic factors
Guy Lahat et al.
SURGICAL CLINICS OF NORTH AMERICA (2008)
Risks of cancer among a cohort of 23,935 men and women with osteophorosis
Katherine A. McGlynn et al.
INTERNATIONAL JOURNAL OF CANCER (2008)
The association between primary hyperparathyroidism and malignancy: nationwide cohort analysis on cancer incidence after parathyroidectomy
Inga-Lena Nilsson et al.
ENDOCRINE-RELATED CANCER (2007)
Teriparatide [human PTH(1-34)]: 2.5 years of experience on the use and safety of the drug for the treatment of osteoporosis
AH Tashjian et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2006)
BMD and body composition in children and young patients affected by cystic fibrosis
ML Bianchi et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2006)
Defining a noncarcinogenic dose of recombinant human parathyroid hormone 1-84 in a 2-year study in Fischer 344 rats
Jacquelin Jolette et al.
TOXICOLOGIC PATHOLOGY (2006)
Smoking and fracture risk: a meta-analysis
JA Kanis et al.
OSTEOPOROSIS INTERNATIONAL (2005)
Hyperparathyroidism and subsequent incidence of breast cancer
KB Michels et al.
INTERNATIONAL JOURNAL OF CANCER (2004)
Hyperparathyroidism and subsequent cancer risk in Denmark
AL Pickard et al.
CANCER (2002)
Skeletal changes in rats given daily subcutaneous injections of recombinant human parathyroid hormone (1-34) for 2 years and relevance to human safety
JL Vahle et al.
TOXICOLOGIC PATHOLOGY (2002)
Effect of parathyroid hormone (1-34) on fractures and bone mineral density in postmenopausal women with osteoporosis.
RM Neer et al.
NEW ENGLAND JOURNAL OF MEDICINE (2001)
分享论文
